+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Italy In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application (Infectious Disease, Diabetes, Oncology/Cancer), By End-use, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • December 2022
  • Region: Italy
  • Grand View Research
  • ID: 5712482
Description Jump to:
The Italy in vitro diagnostics market size is expected to reach USD 3.74 billion by 2030, set to decline at a CAGR of -1.90% from 2023 to 2030. The growth is driven by the surge in demand for IVD products, owing to the increasing prevalence of target diseases and increasing awareness about early diagnostics of diseases among people. Moreover, the development of automated IVD systems for different healthcare service providers to provide accurate, precise, efficient, and error-free diagnosis is anticipated to boost the Italy IVD market in the coming years.

The Italy IVD market is likely to be supported by the increase in the development of POC tests that allow flexible, precise, easy-to-use, and speedy testing. For instance, in April 2021, DiaSorin launched the LIAISON Quick Detect COVID TrimericS Ab test and LIAISON IQ an immunodiagnostic POC reader. This test can detect specific IgG antibodies in 10 minutes. In addition, LINX DUO, developed by Menarini Diagnostics s.r.l, is a POC multi-assay automated analyzer for HbA1c and CRP testing capable of giving results in a span of a few minutes.

In addition, the companies operating in Italy IVD market are undertaking strategic initiatives such as partnerships and others to strengthen their product portfolio in point-of-care testing. For instance, in July 2020, A. Menarini Diagnostics and Skyla Corporation announced a distribution & supply agreement for LINX DUO multi-assay analyzer and LINX EVO clinical chemistry analyzer. With this partnership, Menarini is expected to strengthen its portfolio for POC diagnostics with state-of-the-art technology.

The increase in the aging population is anticipated to boost the uptake of IVD products thereby facilitating growth. The research found that the geriatric population is more susceptible to chronic diseases and according to the Instituto Superiore di Sanita, over 85% of people over 75 years suffer from chronic diseases. Some major diseases associated with aging are cardiovascular disorders, arthritis, diabetes, autoimmune disorders, and Alzheimer’s disease among others. The increasing risk of developing chronic disease is expected to further support the growth.

Furthermore, government bodies and key market players are taking favorable initiatives to facilitate healthcare services in the country. For instance, in June 2022, Sentinel diagnostics launched SENTiFIT 800 Analyzer, a high throughput and fully automated system for fecal immunochemical tests. Moreover, in April 2021, Lumos Diagnostics and DiaSorin entered into a strategic collaboration for the launch of the point-of-care portable immunoassay platform LIAISON IQ.

Italy In Vitro Diagnostics Market Report Highlights

  • Reagents segment held the largest market share in 2022 owing to increasing demand for clinical tests for targeted diseases
  • Based on the technology, the molecular diagnostics segment dominated Italy in vitro diagnostics (IVD) industry due to the continuous evolution in technology and market introduction of novel products
  • The blood banks segment is anticipated to exhibit the fastest growth rate owing to the rising demand for automated instruments in blood banks and increasing blood transfusions


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2. Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3. Italy In Vitro Diagnostics (IVD) Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Growing geriatric population
3.2.1.2 Technological advancements
3.2.1.3 Increasing demand for PoC facilities
3.2.1.4 Growing prevalence of target diseases
3.2.2 Market restraint analysis
3.2.2.1 Higher cost of devices
3.2.2.2 Stringent regulatory and reimbursement policies
3.3 Penetration & Growth Prospect Mapping
3.4 Italy In Vitro Diagnostics (IVD): Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Italy Glucose Strip Market
3.7 Reagents Market by Application and End Use
Chapter 4. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Product, 2018 - 2030 (Revenue, USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Italy In Vitro Diagnostics (IVD) Market, by Product, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Instruments
4.5.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Reagents
4.5.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3 Services
4.5.3.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Technology 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Technology Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Italy In Vitro Diagnostics (IVD) Market, by Technology, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Immunoassay, by Product
5.5.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.2 Instruments
5.5.1.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.3 Reagents
5.5.1.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.1.4 Services
5.5.1.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Immunoassay, by Technology
5.5.2.1 Radioimmunoassay (RIA)
5.5.2.1.1 Radioimmunoassay (RIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2 Enzyme Immunoassays (EIA)/ELISA
5.5.2.2.1 Enzyme Immunoassays (EIA)/ELISA market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2.2 Chemiluminescence Immunoassays (CLIA)
5.5.2.2.2.1 Chemiluminescence Immunoassays (CLIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.2.3 Fluorescence Immunoassays (FIA)
5.5.2.2.3.1 Fluorescence Immunoassays (FIA) market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.4 Rapid Test
5.5.2.4.1 Rapid test market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2.5 Others
5.5.2.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 Hematology
5.5.3.1 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.2 Instruments
5.5.3.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.3 Reagents
5.5.3.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3.4 Services
5.5.3.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4 Clinical Chemistry
5.5.4.1 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.2 Instruments
5.5.4.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.3 Reagents
5.5.4.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4.4 Services
5.5.4.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5 Molecular Diagnostics/Genetics, by Product
5.5.5.1 Molecular diagnostics/genetics market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.2 Instruments
5.5.5.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.3 Reagents
5.5.5.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5.4 Services
5.5.5.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6 Molecular Diagnostics/Genetics, by Technology
5.5.6.2 Polymerase Chain Reaction (PCR)
5.5.6.2.1 PCR market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.3 Sequencing
5.5.6.3.1 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.4 Hybridization
5.5.6.4.1 Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.5 Chips & Microarrays
5.5.6.5.1 Chips & microarrays market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.6 TMA
5.5.6.6.1 TMA market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.7 INAAT
5.5.6.7.1 INAAT market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.8 Mass Spectrometry
5.5.6.8.1 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6.9 Others
5.5.6.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7 Coagulation
5.5.7.1 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.2 Instruments
5.5.7.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.3 Reagents
5.5.7.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7.4 Services
5.5.7.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8 Microbiology
5.5.8.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.2 Instruments
5.5.8.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.3 Reagents
5.5.8.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.8.4 Services
5.5.8.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9 Others
5.5.9.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.2 Instruments
5.5.9.2.1 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.3 Reagents
5.5.9.3.1 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
5.5.9.4 Services
5.5.9.4.1 Services market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Application, 2018 - 2030 (Revenue, USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Italy In Vitro Diagnostics (IVD) Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Infectious Disease
6.5.1.1 Infectious disease market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Diabetes
6.5.2.1 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3 Oncology/Cancer
6.5.3.1 Oncology/Cancer market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4 Cardiology
6.5.4.1 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5 Nephrology
6.5.5.1 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6 Autoimmune Diseases
6.5.6.1 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7 Drug Testing
6.5.7.1 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
6.5.8 Others
6.5.8.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By End Use, 2018 - 2030 (Revenue, USD Million)
7.1 Definition and Scope
7.2 End Use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Italy In Vitro Diagnostics (IVD) Market, by End Use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Core Lab
7.5.1.1 Core lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2 SWA, by Location
7.5.1.2.1 SWA market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.2 Public Hospitals
7.5.1.2.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.3 Large Private Hospitals
7.5.1.2.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.4 Private
7.5.1.2.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3 SWA, by Type
7.5.1.3.1 Clinical Chemistry
7.5.1.3.1.1 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.2.2 Immunochemistry
7.5.1.2.2.1 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3 Hematology
7.5.1.3.1 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.2 Public Hospitals
7.5.1.3.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.3 Large Private Hospitals
7.5.1.3.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.3.4 Private
7.5.1.3.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4 Coagulation
7.5.1.4.1 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.2 Public Hospitals
7.5.1.4.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.3 Large Private Hospitals
7.5.1.4.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.4.4 Private
7.5.1.4.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5 Urine Test
7.5.1.5.1 Urine Test market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.2 Public Hospitals
7.5.1.5.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.3 Large Private Hospitals
7.5.1.5.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.5.4 Private
7.5.1.5.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.1.6 Others
7.5.1.6.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Molecular Lab
7.5.2.1 Molecular Lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.2 HPV
7.5.2.2.1 HPV market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.3 Herpetics
7.5.2.3.1 Herpetics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.4 Hepatitis
7.5.2.4.1 Hepatitis market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.5 HIV
7.5.2.5.1 HIV market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.6 NIPT
7.5.2.6.1 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2.7 Others
7.5.2.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Pathology Lab
7.5.3.1 Pathology Lab market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2 Advanced Staining (Immunohistochemistry)
7.5.3.2.1 Advanced staining (Immunohistochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.2 Public Hospitals
7.5.3.2.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.3 Large Private Hospitals
7.5.3.2.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.2.4 Private
7.5.3.2.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3 Primary Staining (Hematoxylin Eosin and Histochemistry)
7.5.3.3.1 Primary staining (Hematoxylin Eosin and Histochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.2 Public Hospitals
7.5.3.3.2.1 Public hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.3 Large Private Hospitals
7.5.3.3.3.1 Large private hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3.3.4 Private
7.5.3.3.4.1 Private market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Blood Banks
7.5.4.1 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.2 SWA
7.5.4.2.1 SWA market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.3 Molecular Test
7.5.4.3.1 Molecular test market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4 Point of Care (PoC)
7.5.4.1 Point of Care (PoC) market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.2 Clinics
7.5.4.2.1 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.3 Hospitals
7.5.4.3.1 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.4 Retail
7.5.4.4.1 Retail market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.5 Military premises
7.5.4.5.1 Military premises market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.6 Airports
7.5.4.6.1 Airports market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4.7 Others
7.5.4.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5 Others
7.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.2 NGS
7.5.5.2.1 NGS market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.3 Mass Spectrometry
7.5.5.3.1 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5.4 Others
7.5.5.4.1 Others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Italy In Vitro Diagnostics (IVD) Market Segment Analysis, By Region, 2018 - 2030 (Revenue, USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 Italy
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
8.6.1 Italy
8.6.1.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Italy In Vitro Diagnostics (IVD) Market - Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4. Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 F. Hoffmann-La Roche Ltd.
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Abbott
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 bioMerieux SA
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Danaher
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 QIAGEN
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 BD
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 Sysmex Corporation
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 DiaSorin S.p.A.
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 The Menarini Group
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 SENTINEL CH. SpA
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives
9.6.11 Quidel Corporation.
9.6.11.1 Company overview
9.6.11.2 Financial performance
9.6.11.3 Product benchmarking
9.6.101.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Italy In Vitro Diagnostics (IVD) Market, By Region, 2018 - 2030 (USD Million)
Table 5 Italy In Vitro Diagnostics (IVD) Market, By Product, 2018 - 2030 (USD Million)
Table 6 Italy In Vitro Diagnostics (IVD) Market, By Technology, 2018 - 2030 (USD Million)
Table 7 Italy In Vitro Diagnostics (IVD) Market, By Application, 2018 - 2030 (USD Million)
Table 8 Italy In Vitro Diagnostics (IVD) Market, By End Use, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Italy In Vitro Diagnostics (IVD) market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Italy In Vitro Diagnostics (IVD) market: Product movement analysis
Fig. 17 Italy In Vitro Diagnostics (IVD) market: Product segment dashboard
Fig. 18 Italy In Vitro Diagnostics (IVD) market: Product outlook: Key takeaways
Fig. 19 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Services medication market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Italy In Vitro Diagnostics (IVD) market: Technology movement analysis
Fig. 23 Italy In Vitro Diagnostics (IVD) market: Technology segment dashboard
Fig. 24 Italy In Vitro Diagnostics (IVD) market Technology outlook: Key takeaways
Fig. 25 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Radioimmunoassay (RIA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 ELISA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Chemiluminescence Immunoassay (CLIA) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Fluorescence Immunoassays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Rapid Test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Clinical Chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 PCR market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Hybridization market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Chips & Microarrays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 TMA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 INNAT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Mass Spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Italy In Vitro Diagnostics (IVD) market: Application movement analysis
Fig. 46 Italy In Vitro Diagnostics (IVD) market: Application segment dashboard
Fig. 47 Italy In Vitro Diagnostics (IVD) market Application outlook: Key takeaways
Fig. 48 Infectious Disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Oncology/Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Drug Testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Italy In Vitro Diagnostics (IVD) market: End Use movement analysis
Fig. 57 Italy In Vitro Diagnostics (IVD) market: End Use segment dashboard
Fig. 58 Italy In Vitro Diagnostics (IVD) market End Use outlook: Key takeaways
Fig. 59 Core Lab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 SWA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 Urine test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Molecular Lab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 HPV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Herpetics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Hepatitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 HIV market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 NIPT market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Pathology lab market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Advanced staining (Immunohistochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Primary staining (Hematoxylin Eosin and Histochemistry) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Blood banks market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 SWA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Molecular test market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 PoC market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 NGS market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Regional outlook, 2022 & 2030
Fig. 86 Regional market dashboard
Fig. 87 Regional market place: Key takeaways
Fig. 88 Italy, SWOT
Fig. 89 Italy
Fig. 90 Italy in vitro diagnostics (IVD) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Ansoff Matrix
Fig. 92 Heat map analysis
Fig. 93 Market differentiators

Companies Mentioned

  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • bioMerieux SA
  • Danaher
  • QIAGEN
  • BD
  • Sysmex Corporation
  • DiaSorin S.p.A.
  • The Menarini Group
  • SENTINEL CH. SpA
  • Quidel Corporation.

Methodology

Loading
LOADING...

Related Topics

Related Reports

In Vitro Diagnostics - Global Strategic Business Report - Product Image

In Vitro Diagnostics - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Coagulation, Molecular Diagnostics) By Application, End-use, Country, and Segment Forecasts, 2023-2030 - Product Image

Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), Technology (Coagulation, Molecular Diagnostics) By Application, End-use, Country, and Segment Forecasts, 2023-2030

  • Report
  • 85 Pages
  • Europe
From
In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2024-2032 - Product Image

In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

IVD In Cardiology And Neurology Market Size, Share & Trends Analysis Report By Product Type (Instruments, Reagents & Consumables), By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031 - Product Image

Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031

  • Report
  • 209 Pages
  • Europe
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.